News
7h
Medpage Today on MSNPfizer Confirms: Leading JAK Inhibitor Often Comes With Weight GainAfter 6 months, placebo was associated with a mean weight gain of 0.4 kg (o.88 lb), compared with 1.2-1.9 kg (2.6-4.2 lb) ...
Best Pharma Stocks to Invest in Now. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands ...
Although the immediate market response was negative, most pharmaceutical stocks recovered after Wall Street analysts ...
6hon MSN
There are significant questions on how the order can be implemented, and if companies can raise prices on already approved ...
But when a dividend yield reaches ultrahigh levels, investors can feel a heightened level of uncertainty. Wondering if Pfizer ...
Albert Bourla said Pfizer is being "frugal" with investments because of the uncertainty surrounding tariffs.
A combination of the HER2 agent, called disitamab vedotin, and Junshi Biosciences’ PD-1 inhibitor toripalimab outperformed ...
Big pharmaceutical companies as well as smaller biotechs have been hoping to score a win in one of today's highest-growth ...
For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...
Shares of Asian drugmakers are falling after President Trump said he would [sign an executive order]( ...
After years of falling Covid treatment sales, lukewarm drug launches and a fizzled out weight-loss play, Pfizer is focusing on cost-cutting and reinvesting in new drug research in hopes that it can ...
We recently published a list of 13 Stock Predictions That Jim Cramer Got Completely Wrong. In this article, we are going to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results